Laura Indolfi Email and Phone Number
Laura Indolfi work email
- Valid
- Valid
- Valid
Laura Indolfi personal email
Laura Indolfi phone numbers
Laura Indolfi is the Co-Founder & CEO of PanTher Therapeutics, a clinical-stage oncology company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site. Under her leadership, the company has advanced its lead drug candidate, PTM-101, from preclinical R&D studies to clinical trials for the treatment of pancreatic cancer. Laura has raised equity and grant funding for PanTher since its inception in 2016 and built an experienced leadership team to guide the company’s success. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledge to drive the company’s vision. Prior to PanTher, she was a research associate at the Harvard-MIT Institute for Medical Engineering and Science, and served as an entrepreneur-in-residence at the MGH Cancer Center. She strongly believes in the power of outreaching initiatives to promote research awareness and foster the public audiences discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience. In 2016, she was named a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, she attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing executives, entrepreneurs and innovators in business. Laura is also one of the 5 women selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of MassNextGen program, honoring exceptional leaders in the biotech industry. SPECIALTIES:* Multiple therapeutic areas, * Inflammatory/cardiovascular/neoplastic diseases, * smart biomaterials, * biodegradable polymers,* local, controlled and sustained drug delivery, * cell therapies,* translational medicine,* start up,* entrepreneurship,* strategic planning.
Panther Therapeutics
View-
Founder And CeoPanther Therapeutics May 2016 - PresentAustin, Texas, UsPanTher Therapeutics is a clinical-stage oncology company offering transformational localized treatment of cancer. This is accomplished through its platform which enables continuous, high-dose treatment of potent oncology agents exclusively at the site of a tumor. PanTher’s proprietary treatment platform, is a polymer-based system that allows therapeutic agents to be formulated in a wide range of dosage forms that can be administered to the surface of a cancerous organ or implanted directly into a tumor. The drug product is designed to continuously deliver drug for weeks or months at a desired dose level, without unwanted dose-limiting side effects. PanTher’s lead clinical candidate, PTM-101, has successfully been evaluated in a Phase 1 clinical trial in treatment naïve localized non-metastatic pancreatic cancer patients. PanTher is now preparing to initiate a Phase 1b trial of PTM-101, to further assess safety, tolerability, and anti-tumor activity across two different dose levels. In addition, PanTher is exploring opportunities to utilize its platform technology in additional solid tumor indications.
-
Founding Member BostonChief 2020 - PresentNew York, Ny, UsChief is a private network built to drive more women into positions of power and keep them there. Chief is the only organization specifically designed for senior women leaders to strengthen their leadership journey, cross-pollinate ideas across industries, and effect change from the top-down.Chief Boston is officially launching this fall and we’ll soon be in touch with exciting updates. -
Advisory Board MemberWest - Women In The Enterprise Of Science And Technology Jan 2020 - PresentCambridge, Ma, UsWEST is a learning community that provides women in the enterprise of science and technology with the inspiration, knowledge, and connections to reach their full potential. Advisory board members provide strategic contributions to accomplish WEST’s mission. -
Ted FellowTed Conferences Dec 2015 - PresentNew York, Ny, Us -
Massnextgen InitiativeMassachusetts Life Sciences Center 2018 - 2019Waltham, Massachusetts, UsThe MassNextGen initiative is designed to support women entrepreneurs, giving them the tools they need to succeed. These tools include expanding their network, increased visibility within the ecosystem, and directly investing in their ventures via non-dilutive capital. -
Chair Of Cardiovascular Special Interest Group (Sig)American Society For Biomaterials (Sfb) Apr 2015 - Apr 2017
-
Member Health Innovation Hub Cohort 2016Springboard Enterprises 2016 - 2017Mclean, Virginia, UsSpringboard’s Health Innovation Hub: Life Science is a program for women-led healthcare and life science companies seeking seed and growth funding and expert connections to develop solutions in pharma, including new drugs, diagnostics, pharma technologies, and drug-delivery devices.Selected companies will be matched with a team of relevant, targeted advisors and participate in several in-person and virtual workshops and presentation sessions throughout the year that provide exposure to influencers, active investors, and potential strategic partners. -
Massconnect Mentorship ProgramMassbio Oct 2015 - Jan 2016Cambridge, Massachusetts, UsMassBio’s MassCONNECT program is the only entrepreneur mentorship program in Massachusetts that dives deep into the life sciences. MassCONNECT matches entrepreneurs and founders with seasoned life sciences professionals to catalyze and commercialize innovation. The MassCONNECT process involves a two-month mentorship where industry experts guide entrepreneurs as they seek to develop business plans, launch companies, and raise capital. MassCONNECT mentors evaluate and provide feedback on commercial feasibility; identify strengths, weaknesses, opportunities and threats; and team up to furnish industry-specific business advice for innovative ideas in therapeutics, diagnostics, medical devices and health IT. Entrepreneurs gain invaluable advice and coaching on defining value proposition, developing pitches and building professional networks. -
Entrepreneur In Residence - Research FellowMassachusetts General Hospital Cancer Center Aug 2014 - 2016Boston, Ma, Us- Scaled-up clinically relevant prototype of drug eluting device to locally treat pancreatic cancer. - Conducted interviews with leading physicians to test the expansion of this therapy to other unmet clinical needs. -
Post-Doc Researcher AssociateMit Jul 2008 - 2016Cambridge, Ma, UsPostdoctoral Associate, Professors Elazer Edelman and Robert Langer.- Created prototype of implantable drug delivery platforms for the treatment of pancreatic cancer. Tailored drug-polymer formulations for tuning release kinetics. Evaluated business potential to translate into clinic.- Investigated cell-material interactions in tissue engineered three-dimensional polymeric matrices. Discovered that architectural properties determine cell function and immune phenotype. Work featured on MIT webpage (http://web.mit.edu/site/spotlight/3473) and at the Society for Biomaterials Conference 2011. - Optimized cell seeding and culture conditions in tissue-engineered cardiovascular device: 50% reduction of manufacturing time, 2x increase of number of cells, enhanced biological activity and efficiency. - Collaborated with industrial partner, Pervasis Therapeutics (recently acquired by Shire), currently testing its core technology Vascugel® in phase 3 clinical trials. Coordinated operational and experimental approaches aimed at incorporating new research results in their current product line. -
2015 Boston FellowStartup Leadership Program Sep 2014 - Aug 2015Boston, Massachusetts, UsHand-picked as one of the 24 Boston Fellows for the Startup Leadership Program (SLP), a highly selective, 60-hour, 6-month world-class training program and lifetime network for outstanding founders and innovators. SLP Fellows have founded 700 companies that have raised $370 million. http://www.startupleadership.com -
Project ManagerPib - Professional Italians In Boston 2011 - 2015Boston, UsRole: Coordinate internal meetings, strategic planning and execution of events, group management.PIB is new, non-profit and apolitical enterprise founded in May 2009, which now counts on more than 600 members. The association is a networking platform for professional Italians in Boston who eager to meet their peers to enhance collaborations and continue on a trends of developments which have contributed to the American economy and its progress in general. The group also foresees the opportunity to become a functional channel between the excellence of the Italian peninsula and the Boston community. -
Strategic Decision Making In The Life SciencesMit Sloan School Of Management Feb 2012 - May 2012Cambridge, Ma, UsProfessors Jonathan Fleming, Andrey Zarur.- Mastered use of TreeAgePro2012 software for decision trees creation and probabilities analysis of strategic decisions faced by managers, investors and scientists in the value chain of life science industry. -
Apprentice ConsultantThe Boston Consulting Group Jun 2011 - Jul 2011Boston, Massachusetts, UsOne of 24 Ph.D. candidates selected (out of over 150 applicants) - Interacted extensively with BCG consultants and worked in a team on a mock case to devise turnaround strategy for a consumer good company. - Developed key consulting skills, performed analysis on profit and loss statement, interviewed C-level executives, delivered final presentation. -
Commercializing ScienceHarvard Business School Sep 2010 - Dec 2010Boston, Ma, UsBiomedical and Life Science Track, Professor Vicki Sato.- Developed the commercialization plan for an injectable drug delivery technology launched in Prof. David Mooney’s laboratory; Cardiovascular field. - Assessed the proposed technology on the basis of pre-clinical data and competition analyses. Performed market, financial and operational analyses. Presented results and proposed road-map to the inventor. -
Student - Biomedical Enterprise ProgramMit Sloan School Of Management Feb 2010 - Aug 2010Cambridge, Ma, UsBiomedical Enterprise Program (BEP), Professors Richard Cohen and Stanley Lapidus.- Performed extensive analysis utilizing methodologies from top consulting firms concerning evaluation of science, patent portfolio, outsourcing issues, scale-up manufacturing issues affecting business plan of an early stage start-up focused on a point-of-care diagnostic system for HIV disease monitoring.- Conducted in-depth research on scientific literature, including patents and FDA labels, to evaluate clinical controversies in emerging technologies for lung cancer screening with an emphasis in clinical trial design, end point choice and financial incentives. - Outlined a potential cost containment structure for standardization of medical devices uses in health care facilities that addressed the challenges of FDA approval, reimbursement strategies, and physician preference items.
-
Ph.D. In Biomaterials EngineeringUniversity Of Naples Nov 2004 - Jan 2008PhD student, Professor Paolo Netti.During my PhD thesis I worked on Biomaterials for Cardiovascular devices. In particular I focused my project on design, realize and optimize a novel Drug Eluting Stent able to overcome the intrinsic limitations of devices present on the market.- Conducted studies on degradation kinetics and transport phenomena of PLGA microspheres. Identification of critical parameters in multicomponent systems design for delivery platform with tunable release kinetics. - Customized hydrogel coating process for cardiovascular prostheses: spray-coating techniques and experimental polymer science. Designed and developed an innovative drug eluting stent (DES) based on biodegradable PLGA particles, innovation lay in controlled release of multiple agents simultaneously or in sequence addressing main limitation of currently available medical devices. Prototype manufactured.- Prepared reviews, reports, oral presentations and training materials for undergrad and grad students and internal/external meetings.
-
Summer StudentInternational Center For American English (Icae) 2005 - 2005
-
Erasmus StudentEcole Nationale Superieure Des Mines De Saint Etienne, France Sep 2001 - Jul 2002Erasmus visiting student
Laura Indolfi Skills
Laura Indolfi Education Details
-
Mit Sloan School Of ManagementBiomedical Enterprise Program -
Università Degli Studi Di Napoli Federico IiMaterials And Structure Engineering
-
Università Degli Studi Di Napoli Federico IiMaterials Science And Engineering
-
École Des Mines De Saint-ÉtienneMaterials Engineering
-
Liceo Scientifico
Frequently Asked Questions about Laura Indolfi
What company does Laura Indolfi work for?
Laura Indolfi works for Panther Therapeutics
What is Laura Indolfi's role at the current company?
Laura Indolfi's current role is CEO of PanTher Therapeutics, TED Fellow, Entrepreneur in residence at MGH Cancer Center.
What is Laura Indolfi's email address?
Laura Indolfi's email address is li****@****mit.edu
What is Laura Indolfi's direct phone number?
Laura Indolfi's direct phone number is +161754*****
What schools did Laura Indolfi attend?
Laura Indolfi attended Mit Sloan School Of Management, Università Degli Studi Di Napoli Federico Ii, Università Degli Studi Di Napoli Federico Ii, École Des Mines De Saint-Étienne, Liceo Scientifico.
What skills is Laura Indolfi known for?
Laura Indolfi has skills like Biomaterials, Lifesciences, Materials Science, Drug Delivery, Science, Tissue Engineering, Laboratory, Life Sciences, Strategic Planning, Regenerative Medicine, Bioengineering, Translational Science.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial